Scalper1 News
Medical-products giants St. Jude Medical (STJ) and Abbott Laboratories (ABT) both beat analysts’ Q2 expectations and raised their guidance Wednesday, though their shares were heading in opposite directions on the stock market today. St. Jude, smaller and specialized mainly in cardiovascular devices, said earnings rose 6% over the year-earlier quarter to $1.02 a share, beating analysts’ consensus by 2 cents. Sales climbed 3% to $1.45 billion, vs. Scalper1 News
Scalper1 News